Related topics: heart attack · cells

Kitchen sponge supercapacitor has many porous benefits

By dipping small pieces of an ordinary kitchen sponge into solutions of nanoscale electrode materials, scientists have created a light-weight, low-cost supercapacitor that benefits from the sponge's porous structure. The ...

Size matters in particle treatments of traumatic injuries

Traumatic injuries are the leading cause of death in the U.S. among people 45 and under, and such injuries account for more than 3 million deaths per year worldwide. To reduce the death toll of such injuries, many researchers ...

Platelets instead of spheres make screens more economical

ETH scientists have further developed QLED technology for screens. They have produced light sources that for the first time emit high-intensity light in only one direction. This reduces scattering losses, which makes the ...

page 1 from 5

Platelet

Platelets, or thrombocytes (from Greek θρόμβος, "clot" and κύτος, "cell"), are small, irregularly shaped clear cell fragments (i.e. cells that do not have a nucleus containing DNA), 2–3 µm in diameter, which are derived from fragmentation of precursor megakaryocytes.  The average lifespan of a platelet is normally just 5 to 9 days. Platelets are a natural source of growth factors. They circulate in the blood of mammals and are involved in hemostasis, leading to the formation of blood clots.

If the number of platelets is too low, excessive bleeding can occur. However, if the number of platelets is too high, blood clots can form (thrombosis), which may obstruct blood vessels and result in such events as a stroke, myocardial infarction, pulmonary embolism or the blockage of blood vessels to other parts of the body, such as the extremities of the arms or legs.  An abnormality or disease of the platelets is called a thrombocytopathy, which could be either a low number of platelets (thrombocytopenia), a decrease in function of platelets (thrombasthenia), or an increase in the number of platelets (thrombocytosis). There are disorders that reduce the number of platelets, such as heparin-induced thrombocytopenia (HIT) or thrombotic thrombocytopenic purpura (TTP) that typically cause thromboses, or clots, instead of bleeding.

Platelets release a multitude of growth factors including Platelet-derived growth factor (PDGF), a potent chemotactic agent, and TGF beta, which stimulates the deposition of extracellular matrix.  Both of these growth factors have been shown to play a significant role in the repair and regeneration of connective tissues.  Other healing-associated growth factors produced by platelets include basic fibroblast growth factor, insulin-like growth factor 1, platelet-derived epidermal growth factor, and vascular endothelial growth factor.  Local application of these factors in increased concentrations through Platelet-rich plasma (PRP) has been used as an adjunct to wound healing for several decades.

This text uses material from Wikipedia, licensed under CC BY-SA